An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Article purchase
Temporarily unavailable
References
1
Orrú, CD, Groveman, BR, Hughson, AG, et al.Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid. mBio. 2015;6(1):e02451. doi: 10.1128/mBio.02451-14.CrossRefGoogle ScholarPubMed
2
Slota, AJ, Myskiw, J, Peterson, A, et al.Diagnosis of Creutzfeldt-Jakob disease in Canada: An update in cerebrospinal fluid testing from 2016–2024. Can J Neurol Sci. 2025;1–23.10.1017/cjn.2025.10088CrossRefGoogle Scholar
3
Green, AJE.RT-QuIC: a new test for sporadic CJD. Pract Neurol. 2019;19(1):49–55. doi: 10.1136/practneurol-2018-001935.CrossRefGoogle ScholarPubMed
4
Hermann, P, Schmitz, M, Cramm, M, et al.Application of real-time quaking-induced conversion in Creutzfeldt-Jakob disease surveillance. J Neurol. 2023;270(4):2149–2161. doi: 10.1007/s00415-022-11549-2.CrossRefGoogle ScholarPubMed
5
Fiorini, M, Iselle, G, Perra, D, et al.High diagnostic accuracy of RT-QuIC assay in a prospective study of patients with suspected sCJD. Int J Mol Sci. 2020;21(3):880. doi: 10.3390/ijms21030880.CrossRefGoogle Scholar
6
Mok, T, Jaunmuktane, Z, Susan, J, et al. Variant Creutzfeldt-Jakob disease in a patient with heterozygosity at PRNP codon 129. N Engl J Med. 2017;376(3):292–294. doi: 10.1056/NEJMc1610003.CrossRefGoogle Scholar
Target article
Diagnosis of Creutzfeldt-Jakob Disease in Canada: An Update on Cerebrospinal Fluid Testing from 2016 to 2024
Related commentaries (2)
Reviewer Comment on Slota et al. “Diagnosis of Creutzfeldt-Jakob Disease in Canada: An Update on Cerebrospinal Fluid Testing from 2016–2024”
Reviewer Comment on Slota et al. “Diagnosis of Creutzfeldt-Jakob Disease in Canada: An Update on Cerebrospinal Fluid Testing from 2016–2024”